article thumbnail

Outcomes of Patients With vs. Without Pre-Ablation Transesophageal Echocardiogram

American College of Cardiology

Patients undergoing atrial fibrillation (AFib) ablation who were not properly anticoagulated and did not undergo preprocedural transesophageal echocardiogram (TEE) were significantly more likely to suffer from transient ischemic attack (TIA) or pulmonary embolism (PE).

article thumbnail

Comparison of approaches to determine echocardiographic outcomes for children with latent rheumatic heart disease

Open Heart

Methods A four-member expert panel reviewed 799 enrolment (in 2018) and completion (in 2020) echocardiograms from the GOAL Trial of latent RHD in Uganda to make consensus determination of normal, borderline RHD or definite RHD. Results There were 799 pairs of echocardiogram assessments included.

article thumbnail

See how bad the outcome can be if you don't know OMI findings on the ECG, and don't use the Queen of Hearts

Dr. Smith's ECG Blog

An echocardiogram showed severely reduced global systolic function with an EF of 20-25% and an LV apical thrombus. An echocardiogram showed an EF of 20-25%. The scan did not find PE, but showed evidence of coronary plaque: There are areas of dense white in the LAD (red and blue circles) and in the first diagonal (green circle).

Outcomes 112
article thumbnail

A 40-something woman with acute pulmonary edema -- see the Speckle Tracking echocardiogram.

Dr. Smith's ECG Blog

Outcome : She was diagnosed with stress cardiomyopathy, though it is not entirely classic. Here is the next day ECG: Very bizarre wide T-wave inversions in anterior and high lateral leads, with long QT. Morphology is very typical for takotsubo, but focality is not. It is usually more diffuse, including inferior leads.

article thumbnail

Impact of elevated left ventricular filling pressure on long-term outcomes after transcatheter aortic valve replacement

Open Heart

However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. The presence of elevated FP was determined in accordance with the latest guidelines using the last available comprehensive echocardiogram prior to TAVR.

article thumbnail

Abstract 4142210: Stroke Risk in Patients with Cardioversion of Newly Diagnosed Persistent Atrial Fibrillation with and without Transesophageal Echocardiogram for Left Atrial and Left Atrial Appendage Thrombus Assessment

Circulation

The importance of transesophageal echocardiogram (TEE) to exclude left atrial (LA) and left atrial appendage (LAA) thrombus prior to cardioversion for atrial fibrillation (AF) has been debated in patients who are anticoagulated prior to cardioversion. Primary outcomes measured were the incidence of stroke within one-year post-cardioversion.

article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. Lantheus announced that the U.S.